Table 1.
n | % | |
---|---|---|
Gender, female (n = 2,654) | 1,659 | 62.5% |
| ||
Insurance status, public (n = 2,587) | 2,494 | 96.4 |
| ||
Nonsmoker (n = 2,638) | 2,052 | 77.8 |
| ||
Patients with ≥1 self-reported chronic condition | 1,086 | 39.9 |
Hypertension | 608 | 56 |
Chronic pain/arthritis | 257 | 23.7 |
Heart disease | 242 | 22.3 |
Diabetes | 221 | 20.3 |
Asthma/chronic bronchitis | 197 | 18.1 |
Depression | 143 | 13.2 |
Chronic kidney disease | 55 | 5.1 |
| ||
Age, mean ± SD (n = 2,644) | 46.7 ± 16.8 | |
| ||
Years of formal education, mean ± SD (n = 2,557) | 12.8 ± 4.49 | |
| ||
Number of tablets used daily, mean ± SD (n = 2,318) | 2.0 ± 2.7 | |
Patients with ≥1 tablet daily (n = 1,467) | ||
ASA/aspirin | 314 | 21.4 |
Oral contraceptive | 165 | 11.2 |
Anticoagulants | 80 | 5.5 |
| ||
Participating countries (n = 2,724) | ||
Austria° | 110 | 4 |
Finland# | 107 | 3.9 |
France, 3 sites+# | 325 | 11.9 |
Germany, 3 sites+°# | 385 | 14.1 |
Israel+ | 123 | 4.5 |
Italy, 2 sites#° | 161 | 5.9 |
Macedonia° | 364 | 13.4 |
Poland, 2 sites+ | 241 | 8.8 |
Slovenia° | 119 | 4.4 |
Spain+ | 86 | 3.2 |
Sweden+ | 98 | 3.6 |
Turkey, 5 sites°+ | 605 | 22.2 |
°Mixed (urban/rural); +urban; #rural.